Abstract submission

RSNA's Cutting-Edge Research call for abstracts is open!

Your discoveries have the power to impact the future of individuals worldwide. Don't miss the final opportunity to showcase your groundbreaking research at RSNA 2025.

Submit your abstract

We're accepting research on the following topics:

Opportunistic Screening: Enhancing Diagnostic Impact from Routine Imaging 

This topic explores how radiologists can extract additional, clinically-relevant information from routine imaging studies performed for other indications, such as: 

  • Body composition 
  • Assessing bone mineral density 
  • Identifying coronary artery calcifications on CT  
By leveraging data in existing imaging, opportunistic screening represents a potentially cost effective and data-rich avenue for early disease detection to optimize population health. New results at large scale, exploration of issues of clinical acceptance and biomarker validation are some examples of topics of interest within this arena. 
Translating Innovation: Radiologist–Industry Collaboration in Clinical Integration of New Technologies 

Focusing on the dynamic interface between scientific discovery and clinical application, this topic highlights research that results from collaboration between radiologists and industry.  
 
Submissions may include:  

  • Co-development and real-world deployment of AI applications, including:  
    • Diagnostic support tools 
    • Workflow optimization platforms 
    • Imaging triage systems 
  • Advances in imaging hardware and software 
Emphasis is placed on novelty, regulatory navigation, clinical validation, integration into radiology workflows, post-deployment monitoring and measurable impact on patient care. 
Next-Generation Imaging: Advances in Low- and Non-Contrast Techniques 

This topic addresses innovative imaging methods that minimize or eliminate the need for exogenous contrast, including: 

  • Development of novel sequences 
  • Clinical implementation 
  • Comparative effectiveness 
  • Cost analysis 
  • Environmental benefits 
  • Safety 
  • Diagnostic efficacy 
Imaging-Guided Oncologic Therapies: From Histotripsy to Theranostics and Beyond 
This topic examines the frontier of imaging-enabled cancer therapies, including non-invasive ablation techniques like histotripsy and molecularly-targeted agents used in theranostics.  
 
Emphasis is placed on how radiologists are central to both the diagnostic and therapeutic continuum in precision oncology through image-guided delivery and response assessment. 
High-Impact Clinical Trials in Radiology  
This abstract call is intended for high-impact imaging clinical trials based on late-breaking data (after May 7, 2025). Accepted abstracts will be featured in dedicated sessions at RSNA 2025. 

Abstracts must meet the following criteria: 
  • Prospective study design 
  • Conducted across multiple centers 
  • Centered on radiology or medical imaging 
  • Demonstrate clear potential to impact clinical practice 
  • Include data/outcomes collected after May 7, 2025 
  • Not submitted during the spring RSNA 2025 call for abstracts 
Abstracts may be presented at a non-imaging scientific meeting in the same calendar year or later. 

Submission deadline

Submit your work to the Cutting-Edge Research call for abstracts by Aug. 6, noon CT. Authors can expect to receive submission status notifications by email.

Please note: Accepted presenters of a scientific paper, scientific poster, education exhibit and/or quality improvement reports for the RSNA annual meeting will receive a 50% discount off their in-person registration rate.

Submit now

Contact us

If you have questions, please contact us at programs@rsna.org or call 1-877-776-2227 (within U.S.) or 1-630-590-7774 (outside U.S.).

For technical support, please contact us at rsna@support.ctimeetingtech.com or call 1-217-398-1792.

Types of abstracts

A variety of presentation types provide meeting attendees with wide-ranging opportunities to learn. Abstracts are considered in several formats.
Scientific presentation

Hypothesis-driven research that may be submitted as a paper to be presented orally or as a digital presentation.

Education exhibit

Education exhibits should be designed to teach or review topics related to medical imaging. They may be presented as digital presentations or standalone exhibits.

Quality improvement report

A presentation of quality assessment and improvement initiatives aimed at improving patient care in radiology. Reports will be presented as digital presentations and all require an oral presentation.

Abstract submission overview

Submit abstracts for consideration using an online submission program, which allows you to save and edit your work during the submission period. All abstracts must be submitted online by the posted deadlines in order to be considered for acceptance.

You retain the copyright of your content and agree to give RSNA a limited, nonexclusive, royalty-free license to present and archive the content.

Abstract review process

All abstracts are evaluated through a double-blind peer-review process.

Recognizing excellence

RSNA recognizes top presentations with the following awards.
Kuo York Chynn neuroradiology research award
A $3,000 prize awarded to the top scientific paper in neuroradiology as selected by the Annual Meeting Program Planning Committee.
Trainee research prizes
A $1,000 prize is awarded to an outstanding scientific presentation in each subspecialty presented by a resident, fellow, medical student or physics trainee.
Education exhibit awards
All eligible education exhibits are reviewed by the Education Exhibits Awards Committee appointed by the board of directors and awards are announced at the annual meeting.
Quality improvement report awards
All eligible quality improvement report exhibits are reviewed and awards are announced at the annual meeting.
Scientific poster awards
All eligible scientific posters are reviewed and awards are announced at the annual meeting.
 

RSNA CME Activity Disclosure

Disclosure Refusal Statement
The requirement for financial disclosure from committee members, planners, reviewers, authors, and presenters is a mandatory element in maintaining ACCME accreditation for all organizations that provide continuing education (CE) activities. If an individual refuses to disclose, he/she will not be permitted to participate as a planner, committee member, reviewer, author, or presenter.
*Financial Disclosure

As an ACCME-accredited provider, the RSNA must ensure that education is fair and balanced and that any clinical content presented supports safe, effective patient care. The ACCME defines ineligible companies as "those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients." 

Further, the provider must be able to show that individuals in a position to control the content of an education activity, including committee members, reviewers, planners, authors, and presenters, has disclosed all financial relationships with ineligible companies to the provider. Individuals in a position to control the content must disclose regardless of their view of the relevance of the relationship to the education. The provider must identify, mitigate, and disclose all identified financial relationships to an education activity being delivered to the learners.

If you have or have had within the previous 24 months such a relationship or affiliation, you must disclose this information. Likewise, disclosure that no relationship(s) exists is also required. The intent of this policy is not to prevent an individual with a financial relationship from participating; however, in accordance with ACCME standards, the RSNA has developed policies and procedures to manage identified financial relationships.